337 related articles for article (PubMed ID: 24757653)
1. Hepatic venous pressure gradient: clinical use in chronic liver disease.
Suk KT
Clin Mol Hepatol; 2014 Mar; 20(1):6-14. PubMed ID: 24757653
[TBL] [Abstract][Full Text] [Related]
2. The clinical use of HVPG measurements in chronic liver disease.
Bosch J; Abraldes JG; Berzigotti A; García-Pagan JC
Nat Rev Gastroenterol Hepatol; 2009 Oct; 6(10):573-82. PubMed ID: 19724251
[TBL] [Abstract][Full Text] [Related]
3. Measurement of portal pressure.
Abraldes JG; Sarlieve P; Tandon P
Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
[TBL] [Abstract][Full Text] [Related]
4. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
Thalheimer U; Bellis L; Puoti C; Burroughs AK
Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
[TBL] [Abstract][Full Text] [Related]
5. A computational model of the hepatic circulation applied to analyze the sensitivity of hepatic venous pressure gradient (HVPG) in liver cirrhosis.
Wang T; Liang F; Zhou Z; Shi L
J Biomech; 2017 Dec; 65():23-31. PubMed ID: 29042056
[TBL] [Abstract][Full Text] [Related]
6. Hepatic venous pressure gradient measurement: time to learn!
Kumar A; Sharma P; Sarin SK
Indian J Gastroenterol; 2008; 27(2):74-80. PubMed ID: 18695309
[TBL] [Abstract][Full Text] [Related]
7. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis.
Triantos CK; Nikolopoulou V; Burroughs AK
Aliment Pharmacol Ther; 2008 Oct; 28(8):943-52. PubMed ID: 18627364
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
[TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.
Garcia-Tsao G; Bosch J; Kayali Z; Harrison SA; Abdelmalek MF; Lawitz E; Satapathy SK; Ghabril M; Shiffman ML; Younes ZH; Thuluvath PJ; Berzigotti A; Albillos A; Robinson JM; Hagerty DT; Chan JL; Sanyal AJ;
J Hepatol; 2020 May; 72(5):885-895. PubMed ID: 31870950
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation and treatment of portal hypertension].
Brůha R; Petrtýl J
Cas Lek Cesk; 2016; 155(2):22-6. PubMed ID: 27088788
[TBL] [Abstract][Full Text] [Related]
12. Are there any alternative methods to hepatic venous pressure gradient in portal hypertension assessment?
Procopeţ B; Tantau M; Bureau C
J Gastrointestin Liver Dis; 2013 Mar; 22(1):73-8. PubMed ID: 23539394
[TBL] [Abstract][Full Text] [Related]
13. Complications of cirrhosis. I. Portal hypertension.
Bosch J; García-Pagán JC
J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
[TBL] [Abstract][Full Text] [Related]
14. Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver disease.
Hong WK; Shim KY; Baik SK; Kim MY; Cho MY; Jang YO; Park YS; Han J; Kim G; Cho YZ; Hwang HW; Lee JH; Chae MH; Kwon SO
J Korean Med Sci; 2014 Mar; 29(3):392-9. PubMed ID: 24616589
[TBL] [Abstract][Full Text] [Related]
15. Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
Jindal A; Sharma MK; Vijayaraghavan R; Sm S; Kumar G; Sarin SK
Dig Dis Sci; 2024 Jan; 69(1):298-307. PubMed ID: 37907805
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
[TBL] [Abstract][Full Text] [Related]
17. Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.
Gouya H; Grabar S; Vignaux O; Saade A; Pol S; Legmann P; Sogni P
Eur Radiol; 2016 Jul; 26(7):1981-90. PubMed ID: 26373753
[TBL] [Abstract][Full Text] [Related]
18. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Bosch J; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
[TBL] [Abstract][Full Text] [Related]
19. Measurement of hepatic venous pressure gradient is feasible and safe in children.
Woolfson J; John P; Kamath B; Ng VL; Ling SC
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):634-7. PubMed ID: 23799453
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of 833 times measured hepatic venous pressure gradient].
Zhang MY; Wang GC; Huang GJ; Feng H; Wang LF; Zhang JY; Shi YJ; Zhang CQ
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):266-270. PubMed ID: 29996337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
